246 related articles for article (PubMed ID: 655230)
1. Patient tolerance to carbonic anhydrase inhibitors.
Lichter PR; Newman LP; Wheeler NC; Beall OV
Am J Ophthalmol; 1978 Apr; 85(4):495-502. PubMed ID: 655230
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase inhibitors and osmotic agents in glaucoma. Carbonic anhydrase inhibitors.
Kanski JJ
Br J Ophthalmol; 1968 Aug; 52(8):642-3. PubMed ID: 5724852
[No Abstract] [Full Text] [Related]
3. Carbonic anhydrase inhibitors are antiarthritic in the rat.
Nolan JC; Gathright CE; Radvany CH; Barrett RJ; Sancilio LF
Pharmacol Res; 1991 Dec; 24(4):377-83. PubMed ID: 1805191
[TBL] [Abstract][Full Text] [Related]
4. Ocular hypotensive effects of carbonic anhydrase inhibitors in normotensive and glaucomatous Beagles.
Gelatt KN; Gum G; Williams LW; Gwin RM
Am J Vet Res; 1979 Mar; 40(3):334-45. PubMed ID: 475084
[TBL] [Abstract][Full Text] [Related]
5. [Ocular hypotonic effect of hematic acidifying agents: carbonic anhydrase inhibitors].
Virno M; Pecori-Giraldi J; Pivetti-Pezzi P; Leonardi E
Boll Ocul; 1970 Sep; 49(9):469-91. PubMed ID: 5522152
[No Abstract] [Full Text] [Related]
6. GLAUCOMA TREATED WITH DARANIDE A CLINICAL TRIAL.
Luntz MH
Br J Ophthalmol; 1961 Feb; 45(2):125-9. PubMed ID: 18170651
[No Abstract] [Full Text] [Related]
7. Intraocular pressure effects of carbonic anhydrase inhibitors in primary open-angle glaucoma.
Lichter PR; Musch DC; Medzihradsky F; Standardi CL
Am J Ophthalmol; 1989 Jan; 107(1):11-7. PubMed ID: 2643331
[TBL] [Abstract][Full Text] [Related]
8. Urinary calculi with methazolamide therapy.
Ellis PP
Doc Ophthalmol; 1973 Feb; 34(1):137-42. PubMed ID: 4706085
[No Abstract] [Full Text] [Related]
9. [Topical carbonic anhydrase inhibitors for glaucoma].
Geyer O; Michaeli-Cohen A
Harefuah; 1996 May; 130(10):705-7. PubMed ID: 8794665
[No Abstract] [Full Text] [Related]
10. Topical carbonic anhydrase inhibitors.
Kass MA
Am J Ophthalmol; 1989 Mar; 107(3):280-2. PubMed ID: 2923154
[No Abstract] [Full Text] [Related]
11. A comparison between the effect of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion.
Brechue WF; Maren TH
Exp Eye Res; 1993 Jul; 57(1):67-78. PubMed ID: 8405174
[TBL] [Abstract][Full Text] [Related]
12. Reducing side effects of carbonic anhydrase inhibitors.
Lichter PR
Ophthalmology; 1981 Mar; 88(3):266-9. PubMed ID: 7231916
[TBL] [Abstract][Full Text] [Related]
13. The pharmacology of methazolamide in relation to the treatment of glaucoma.
Maren TH; Haywood JR; Chapman SK; Zimmerman TJ
Invest Ophthalmol Vis Sci; 1977 Aug; 16(8):730-42. PubMed ID: 407172
[No Abstract] [Full Text] [Related]
14. Acetazolamide-like carbonic anhydrase inhibitors with topical ocular hypotensive activity.
Antonaroli S; Bianco A; Brufani M; Cellai L; Lo Baido G; Potier E; Bonomi L; Perfetti S; Fiaschi AI; Segre G
J Med Chem; 1992 Jul; 35(14):2697-703. PubMed ID: 1635066
[TBL] [Abstract][Full Text] [Related]
15. Aplastic anemia resulting from the use of carbonic anhydrase inhibitors.
Wisch N; Fischbein FI; Siegel R; Glass JL; Leopold I
Am J Ophthalmol; 1973 Jan; 75(1):130-2. PubMed ID: 4684255
[No Abstract] [Full Text] [Related]
16. Glaucoma and the applications of carbonic anhydrase inhibitors.
Scozzafava A; Supuran CT
Subcell Biochem; 2014; 75():349-59. PubMed ID: 24146387
[TBL] [Abstract][Full Text] [Related]
17. Topical carbonic anhydrase inhibitors.
Schoenwald RD; Eller MG; Dixson JA; Barfknecht CF
J Med Chem; 1984 Jun; 27(6):810-2. PubMed ID: 6737424
[TBL] [Abstract][Full Text] [Related]
18. Low-dose methazolamide and intraocular pressure.
Stone RA; Zimmerman TJ; Shin DH; Becker B; Kass MA
Am J Ophthalmol; 1977 May; 83(5):674-9. PubMed ID: 17301
[TBL] [Abstract][Full Text] [Related]
19. Hematologic reactions to carbonic anhydrase inhibitors.
Fraunfelder FT; Meyer SM; Bagby GC; Dreis MW
Am J Ophthalmol; 1985 Jul; 100(1):79-81. PubMed ID: 4014383
[TBL] [Abstract][Full Text] [Related]
20. Antiglaucoma carbonic anhydrase inhibitors: a patent review.
Masini E; Carta F; Scozzafava A; Supuran CT
Expert Opin Ther Pat; 2013; 23(6):705-16. PubMed ID: 23627893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]